Trial Profile
Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas of the Prospective, Single Arm Phase II Clinical Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Endostatin (Primary) ; Vinorelbine (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 15 Feb 2016 New trial record